H-89

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

H-89 是一种有效、选择性的 cAMP 依赖性 protein kinase A 抑制剂，IC50 值为 48 nM，对 PKG，PKC，Casein Kinase 和其他激酶的抑制作用很弱。

H-89 is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase, and others kinases.

H-89 inhibits protein kinase A, in competitive fashion against ATP. H-89 causes a dose-dependent inhibition of the forskolin-induced protein phosphorylation, with no decrease in intracellular cyclic AMP levels in PC12D cells. H-89 significantly inhibits the forskolin-induced neurite outgrowth from PC12D cells. H-89 (30 μM) inhibits significantly cAMP-dependent histone IIb phosphorylation activity in PC12D cell lysates. H-89 (1-2 μM) significantly slows the repriming rate in rat skinned fibres, most likely due to it deleteriously affecting the T-system potential. H-89 (10-100 μM) inhibits net Ca2+ uptake by the SR and affectes the Ca32-sensitivity of the contractile apparatus in rat skinned fibres.

H-89 (0.2 mg/100g, i.p.) significantly increases seizure latency and threshold in PTZ-treated animals. H-89 (0.05, 0.2 mg/100 g, i.p.) prevents the epileptogenic activity of bucladesine (300 nM) with significant increase of seizure latency and seizure threshold.

——

Apoptosis

PKA

PKA

——

——

127243-85-0

446.36

C20H20BrN3O2S

>98% (HPLC)

In Vitro:?DMSO 中的溶解度 : 100 mg/mL (224.03 mM; 超声助溶 )

O=S(=O)(NCCNCC=CC1=CC=C(Br)C=C1)C2=CC=CC=3C=NC=CC32

——

(-20℃)

With Ice Pack

≥ 2 years